We have conducted robust clinical studies to establish the principle of CTC based cancer detection and provide evidence for its clinical applications.
Circulating ensembles of tumor-associated cells: A redoubtable new systemic hallmark of cancer.
Author: Akolkar D, Datar Cancer Genetics
Published Date: Nov 30, 2019
Hallmark Circulating Tumor-Associated Cell Clusters Signify 230 Times Higher One-Year Cancer Risk.
Author: Ranade A, Datar Cancer Genetics
Published Date: Sept 21, 2020
Evaluation of circulating tumor cell clusters for pan-cancer noninvasive diagnostic triaging.
Author: Gaya A, Datar Cancer Genetics
Published Date: Sept 30, 2020
Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells.
Author: Limaye S, Datar Cancer Genetics
Published Date: Jan 30, 2023
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells.
Author: O’Neill K, Datar Cancer Genetics
Posted on: Jul 10, 2022
Detection of Circulating Glial Cells Enables Non-Invasive Diagnosis of Glial Malignancies.
Author: O’Neill K, Datar Cancer Genetics
Posted on: Jul 10, 2022
Signup for the latest Certior news, where we’ll share updates on the latest technologies around preventative healthcare.
© 2023 Certior Health Ltd. All rights reserved
